SOPH Executive Chairman Jurgi Camblong Sells 20,000 Shares

What Happened
Jurgi Camblong, Executive Chairman of SOPHiA GENETICS (SOPH), sold 20,000 shares on August 4, 2026. The shares were disposed at a weighted average price of $6.92 per share (range $6.90–$6.98), for total proceeds of approximately $138,412. This was a sale (S) reported on Form 4; insider sales are often routine liquidity events rather than statements about company prospects.

Key Details

• Transaction date: 2026-08-04; Form filed: 2026-08-05 (timely filing).
• Quantity and price: 20,000 shares sold at a weighted average $6.92 (individual trade prices ranged $6.90–$6.98).
• Proceeds: ~ $138,412.
• Shares owned after transaction: Not reported in the provided filing.
• Footnotes: Trade executed pursuant to a Rule 10b5-1(c) trading plan (pre-scheduled); weighted-average price reported, with the filer offering to supply the per-price breakdown on request.

Context: The sale was made under a 10b5-1 plan, which authorizes pre-scheduled trades and helps insiders avoid allegations of trading on nonpublic information. Such planned sales are common and should not be interpreted on their own as a signal about management’s view of the company.